Cargando…
Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608082/ https://www.ncbi.nlm.nih.gov/pubmed/32873864 http://dx.doi.org/10.1038/s41423-020-00537-z |
| _version_ | 1783604766931156992 |
|---|---|
| author | Kabelitz, Dieter Serrano, Ruben Kouakanou, Léonce Peters, Christian Kalyan, Shirin |
| author_facet | Kabelitz, Dieter Serrano, Ruben Kouakanou, Léonce Peters, Christian Kalyan, Shirin |
| author_sort | Kabelitz, Dieter |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7608082 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76080822020-11-05 Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us Kabelitz, Dieter Serrano, Ruben Kouakanou, Léonce Peters, Christian Kalyan, Shirin Cell Mol Immunol Correction Nature Publishing Group UK 2020-09-01 2020-10 /pmc/articles/PMC7608082/ /pubmed/32873864 http://dx.doi.org/10.1038/s41423-020-00537-z Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correction Kabelitz, Dieter Serrano, Ruben Kouakanou, Léonce Peters, Christian Kalyan, Shirin Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us |
| title | Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us |
| title_full | Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us |
| title_fullStr | Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us |
| title_full_unstemmed | Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us |
| title_short | Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us |
| title_sort | correction to: cancer immunotherapy with γδ t cells: many paths ahead of us |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608082/ https://www.ncbi.nlm.nih.gov/pubmed/32873864 http://dx.doi.org/10.1038/s41423-020-00537-z |
| work_keys_str_mv | AT kabelitzdieter correctiontocancerimmunotherapywithgdtcellsmanypathsaheadofus AT serranoruben correctiontocancerimmunotherapywithgdtcellsmanypathsaheadofus AT kouakanouleonce correctiontocancerimmunotherapywithgdtcellsmanypathsaheadofus AT peterschristian correctiontocancerimmunotherapywithgdtcellsmanypathsaheadofus AT kalyanshirin correctiontocancerimmunotherapywithgdtcellsmanypathsaheadofus |